TY - JOUR
AU - Agosti, Jan M.
AB - Concise Communications Subtypes of Legionella pneumophila serogroup 1 as­ methoprim) [2] and was used successfully in one patient sociated with different attack rates. Lancet 1983;2:649-50 [11]. Combined with rifampin, with Legionnaires' disease 6. Bollin GE, Plouffe JF, Para MF, Prior RB. Differences in it was used to treat one patient with Legionella micdadei virulence of environmental isolates of Legionella pneu­ pneumonia [12]. Our study demonstrated the efficacy of mophila serogroup-l (Lp-l). Clinical Research 1984;32: sulfamethoxazole-trimethoprim in a guinea pig model of 364A. L. pneumophila infection following ip injection of the or­ 7. Bopp CA, Sumner JW, Morris GK, Wells JG. Isolation of ganism. While this model obviously differs from the hu­ Legionella species from environmental water samples by man infection, it nonetheless provided an in vivo test of low pH treatment and use of a selective medium. J Clin antibiotic efficacy and has correlated with clinical results. Microbiol 1981;13:714-9 Legionella pneumophila is an intracellular pathogen 8. Wilkinson HW, Fikes BJ, Cruce DD. Indirect im­ munofluorescence test for serodiagnosis of Legionnaires [13J. Sulfamethoxazole-trimethoprim has been shown to disease: evidence for serogroup diversity of Legionnaires be active intracellularly [14] and to be clinically efficacious disease bacterial antigens and for multiple specificity 
TI - Rhabdomyolysis and Acute Renal Failure: A New Presentation of Acute Brucellosis
JF - The Journal of Infectious Diseases
DO - 10.1093/infdis/150.5.782
DA - 1984-11-01
UR - https://www.deepdyve.com/lp/oxford-university-press/rhabdomyolysis-and-acute-renal-failure-a-new-presentation-of-acute-5mox916ifK
SP - 782
EP - 783
VL - 150
IS - 5
DP - DeepDyve
ER -